Get the Stockscreener App
1.13
2.73%
0.03
After Hours:
1.13
Cardiol Therapeutics Inc stock is traded at $1.13, with a volume of 327.48K.
It is up +2.73% in the last 24 hours and up +5.61% over the past month.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
See More
Previous Close:
$1.10
Open:
$1.11
24h Volume:
327.48K
Relative Volume:
0.34
Market Cap:
$97.12M
Revenue:
-
Net Income/Loss:
$-21.65M
P/E Ratio:
-3.4026
EPS:
-0.3321
Net Cash Flow:
$-15.84M
1W Performance:
-5.04%
1M Performance:
+5.61%
6M Performance:
+2.73%
1Y Performance:
-37.22%
1-Day Range:
$1.09
$1.13
1-Week Range:
$1.09
$1.22
52-Week Range:
$0.7709
$2.24
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.13 | 104.64M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jun-26-24 | Initiated | ROTH MKM | Buy |
| Apr-22-24 | Initiated | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Stock (CRDL) Latest News
Is it time to cut losses on Cardiol Therapeutics Inc.Market Movement Recap & Safe Entry Momentum Tips - newser.com
Key metrics from Cardiol Therapeutics Inc.’s quarterly dataQuarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
What market sentiment indicators show for Cardiol Therapeutics Inc. (CT9) stockJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com
Full technical analysis of Cardiol Therapeutics Inc. stockPortfolio Risk Summary & Expert Verified Stock Movement Alerts - newser.com
How Cardiol Therapeutics Inc. stock reacts to inflationary pressuresMarket Activity Report & Free Daily Entry Point Trade Alerts - newser.com
Using Python tools to backtest Cardiol Therapeutics Inc. strategies2025 Year in Review & Daily Stock Trend Reports - newser.com
How Cardiol Therapeutics Inc. stock responds to policy changes2025 Price Targets & Free Long-Term Investment Growth Plans - newser.com
How Cardiol Therapeutics Inc. stock benefits from tech adoptionFed Meeting & Advanced Technical Analysis Signals - newser.com
Can technical indicators confirm Cardiol Therapeutics Inc.’s reversalEarnings Beat & Safe Entry Zone Identification - newser.com
Is Cardiol Therapeutics Inc. stock dividend yield sustainableBreakout Watch & Risk Controlled Swing Trade Alerts - newser.com
How to Take Advantage of moves in (CRDL) (CRDL:CA) - news.stocktradersdaily.com
Why Cardiol Therapeutics Inc. stock is seen as undervaluedJuly 2025 Levels & Reliable Breakout Forecasts - newser.com
Can swing trading help recover from Cardiol Therapeutics Inc. lossesLong Setup & Weekly Return Optimization Plans - newser.com
Is this a good reentry point in Cardiol Therapeutics Inc.2025 Stock Rankings & Expert Curated Trade Setups - newser.com
How to build a custom watchlist for Cardiol Therapeutics Inc.Product Launch & Stepwise Trade Signal Implementation - newser.com
Advanced analytics toolkit walkthrough for Cardiol Therapeutics Inc.July 2025 Recap & Verified Chart Pattern Trade Signals - newser.com
Cardiol Therapeutics’ Phase-3 Trial: A Potential Game-Changer in Recurrent Pericarditis Treatment - MSN
Top chart patterns to watch in Cardiol Therapeutics Inc.Quarterly Earnings Report & Safe Entry Point Alerts - newser.com
Will Cardiol Therapeutics Inc. (CT9) stock see valuation expansionMarket Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
Is Cardiol Therapeutics Inc. stock poised for growthMarket Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
What insider purchases suggest about Cardiol Therapeutics Inc. (CT9) stockJuly 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
Historical volatility pattern of Cardiol Therapeutics Inc. visualized2025 AllTime Highs & Weekly High Return Opportunities - newser.com
How Cardiol Therapeutics Inc. stock reacts to bond yieldsQuarterly Performance Summary & Long-Term Safe Return Strategies - newser.com
Real time social sentiment graph for Cardiol Therapeutics Inc.Options Play & Free Growth Oriented Trading Recommendations - newser.com
Is Cardiol Therapeutics Inc. (CT9) stock undervalued at current priceQuarterly Risk Review & Entry Point Strategy Guides - Fundação Cultural do Pará
Can Cardiol Therapeutics Inc. stock beat market expectations this quarter2025 Historical Comparison & Technical Entry and Exit Alerts - Fundação Cultural do Pará
Is Cardiol Therapeutics Inc. stock supported by strong fundamentalsPortfolio Growth Summary & Growth Focused Investment Plans - Fundação Cultural do Pará
Cardiol Therapeutics Raises $16 Million Through Recent Securities Distribution - TipRanks
(CRDL) Stock Trading Blueprint (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc Stock (CRDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):